Literature DB >> 646246

Carcinoembryonic antigen levels in benign and malignant pleural effusions.

R A Rittgers, M S Loewenstein, A E Feinerman, H Z Kupchik, B R Marcel, R S Koff, N Zamcheck.   

Abstract

One hundred ninety-one unselected fluid specimens submitted routinely for cytologic examination were assayed to determine whether the measurement of carcinoembryonic antigen (CEA) levels in pleural effusions is useful in detecting malignancy. The mean +/- SD CEA level of 103 benign effusions was 4.1 +/- 2.9 ng/ml. Only one benign effusion had a level greater than 12 ng/ml (18 ng/ml). Benign inflammatory effusions (pneumonia, empyema) had a higher mean CEA activity (6.2 +/- 3.4) than effusions caused by congestive heart failure (2.9 +/- 1.5) (p less than 0.001). Twenty-four (34%) of 70 malignant effusions had a CEA level greater than 12 ng/ml, and 28 (40%) were "positive" by cytologic study. Thirty-eight (54%) were detected by one or both methods. Ten malignant effusions were positive by CEA (greater than 12 ng/ml) alone. These data suggest that the determination of CEA activity levels, when used in conjunction with other clinical findings, may be useful in detecting malignant pleural effusions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646246     DOI: 10.7326/0003-4819-88-5-631

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  9 in total

Review 1.  Diagnostic tests in pleural effusion--an update.

Authors:  N Berkman; M R Kramer
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

2.  [Carcinoembryonic antigen (CEA) and CEA-like activities in ascites and pleura-effusions (author's transl)].

Authors:  H Eimermacher; W Tinnefeld; H Pressler; P Schuster; H K Beyer
Journal:  Klin Wochenschr       Date:  1979-06-01

3.  Effect of cigarette smoking, pulmonary inflammation, and lung disease on concentrations of carcinoembryonic antigen in serum and secretions.

Authors:  R A Stockley; J Shaw; A G Whitfield; T P Whitehead; C A Clarke; D Burnett
Journal:  Thorax       Date:  1986-01       Impact factor: 9.139

4.  Tumour associated antigens in diagnosis of serous effusions.

Authors:  J Mezger; W Permanetter; A L Gerbes; W Wilmanns; R Lamerz
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

Review 5.  Diagnosis and treatment of malignant pleural effusion.

Authors:  F H Hausheer; J W Yarbro
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions.

Authors:  M Miédougé; P Rouzaud; G Salama; M C Pujazon; C Vincent; M A Mauduyt; J Reyre; P Carles; G Serre
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

7.  Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer.

Authors:  T Hasegawa; K Isobe; Y Tsuchiya; S Oikawa; H Nakazato; I Nakashima; K Shimokata
Journal:  Br J Cancer       Date:  1993-01       Impact factor: 7.640

8.  Etiologic considerations of nonspecific pleuritis.

Authors:  N J Kim; S C Hong; J O Kim; J W Suhr; S Y Kim; H K Ro
Journal:  Korean J Intern Med       Date:  1991-07       Impact factor: 2.884

9.  Ferritin assay in malignant pleural effusion.

Authors:  W T Chung; J H Lee; J G Park; G I Sohn; S K Park; Y K Shin
Journal:  Korean J Intern Med       Date:  1987-01       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.